EPIC: Enhanced HIV Prevention in Couples: Feasibility Study #3

Sponsor
Columbia University (Other)
Overall Status
Completed
CT.gov ID
NCT02027519
Collaborator
National Institute of Allergy and Infectious Diseases (NIAID) (NIH)
53
2
5
26.5
5.3

Study Details

Study Description

Brief Summary

The purpose of this study is to gather information needed to develop a large prevention trial to decrease risk for Human Immunodeficiency Virus (HIV) transmission among HIV-discordant couples (where one person is HIV-positive and the other is HIV-negative) in Lesotho. The protocol team would like to explore new strategies for increasing the number of partners who receive an HIV test and whether this increase in testing also results in identifying HIV-discordant couples. These couples would be the focus of the future large prevention trial, therefore it is critical that the protocol team explore effective strategies for identifying and recruiting these couples. Men and women (index participants) who are attending Antenatal Care (ANC),Tuberculosis (TB) and antiretroviral therapy (ART) clinics will be recruited for this study. If they agree to take part, a testing team will visit their household and offer all adults staying in the house the opportunity to conduct a self-test for HIV. Seventy-five index participants will be enrolled into the study and have their homes visited by the testing team. The number of household members tested will depend on the number of people living in each household.

Condition or Disease Intervention/Treatment Phase
  • Other: HIV Self-testing with Standard Counseling and Testing (SCT) Confirmation

Detailed Description

In Lesotho, a country with estimated 16% discordance among heterosexual couples, reaching male partners and couples in order to engage them in HIV testing to enable identification of discordant couples is an important first step for any HIV prevention and treatment efforts.

This is a feasibility study of the use of home-based HIV self-testing of partners and household members of individuals recruited from select Antenatal Care (ANC), Tuberculosis (TB) and antiretroviral therapy (ART) clinics in Lesotho. This study uses an observational design to evaluate the feasibility and acceptability of home-based self-testing for HIV testing of partners and the effectiveness of this intervention to identify HIV discordant couples. It is hypothesized that a home-based self-testing intervention will increase the number of partners testing for HIV and will result in increased identification of newly diagnosed HIV-discordant couples, the target population of the planned Enhanced Prevention in Couples (EPIC) study.

Primary objectives of this study include:
  1. To evaluate the feasibility and acceptability of home-based self-testing for HIV testing of partners of index participants

  2. To evaluate the effectiveness of home-based partner self-testing strategies to identify HIV-discordant couples

  3. To evaluate the feasibility and acceptability of home-based self-testing for HIV testing of other household members of index participants

Seventy-five men and women (index participants) will be recruited from antenatal, TB and ART clinics. HIV testing teams will visit index participant households and offer home-based HIV testing to all adult household members.

Study Design

Study Type:
Observational
Actual Enrollment :
53 participants
Time Perspective:
Cross-Sectional
Official Title:
Enhanced HIV Prevention in Serodiscordant Couples Study #3: Feasibility of Home-based Partner Self Testing for HIV
Study Start Date :
Dec 1, 2013
Actual Primary Completion Date :
May 1, 2014
Actual Study Completion Date :
May 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Home-based Self-testing

Index participants who have tested positive for HIV will be provided with information regarding the importance of HIV testing for their partners and other household members and the role of home-based self-testing in potentially increasing the number of partners and household members tested for HIV. In addition, index participants will be counseled about ways in which to talk to partners and household members about HIV testing and provided with information sheets that can be distributed within the household. Lastly, index participants will be introduced to a member of the "testing team" that will present at their home and offer the study intervention.

Other: HIV Self-testing with Standard Counseling and Testing (SCT) Confirmation
Partners of the index participants and other household members will be offered HIV self-testing by the mobile "testing team". Those who consent to HIV self-testing with SCT confirmation will complete the following procedures: Undergo standardized pre-test counseling and demonstration of use of HIV rapid test kit by trained study staff, including how to determine test results Self-administer HIV rapid test and read test results Provide study staff with self-testing result Undergo confirmatory testing as well as post-test counseling by study staff (SCT) if the initial self-test is positive, there is any doubt about the results, or the test reveals couple discordance
Other Names:
  • Self-testing with SCT
  • Outcome Measures

    Primary Outcome Measures

    1. Number of partners tested [9 months]

      Consistent with the primary study objectives of this study, we will evaluate the feasibility of a home-based HIV self-testing strategy by monitoring the number of partners being tested for HIV.

    2. Number of household members tested [9 months]

      Consistent with the primary study objectives of this study, we will evaluate the feasibility of a home-based HIV self-testing strategy by monitoring the number of members of the index participants' households being tested for HIV.

    3. Number of sero-discordant couples identified [9 months]

      We will evaluate the effectiveness of a home-based HIV self-testing strategy by tracking the number of HIV-serodiscordant couples that are identified throughout this study.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    Index Participant

    • Women and men at least 18 years of age

    • Known HIV-positive status

    • Receiving antenatal care or TB/ART care/treatment at participating clinics

    o For men and women recruited from TB clinic: must have been on TB medications for at least 8 weeks

    • Married or living with partner as if married

    o Spouse must be a current member of index participant's household (i.e. married or living with the index participant, and currently residing in Lesotho)

    • Willing to allow study team to visit home and offer HIV counseling and testing to partner and other household members

    • Ability to speak English or Sesotho

    • Willing and able to provide signed informed consent

    Household Members

    • A household member is defined as an individual who:

    • Has been sharing a physical structure such as a compound or homestead with the index participant and who has been consuming or making some contribution to food and other shared household resources

    Guests who stayed at the household the night before will also be offered participation

    • Women and men at least 18 years of age

    • Ability to speak English or Sesotho

    • Willing and able to provide signed informed consent

    Exclusion Criteria:
    • Individuals who do not meet the inclusion criteria outlined above

    • Individuals who report being HIV-infected (Household members only)

    • Any condition which in the opinion of the investigators would interfere with participation in the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mafeteng Hospital Mafeteng Lesotho
    2 Ntseke Hospital Mohale's Hoek Lesotho

    Sponsors and Collaborators

    • Columbia University
    • National Institute of Allergy and Infectious Diseases (NIAID)

    Investigators

    • Principal Investigator: Wafaa M El-Sadr, MD/MPH, ICAP-NY, Columbia University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Wafaa Mahmoud El-Sadr, Director, ICAP, Columbia University
    ClinicalTrials.gov Identifier:
    NCT02027519
    Other Study ID Numbers:
    • AAAM6800
    • 5R01AI083038
    First Posted:
    Jan 6, 2014
    Last Update Posted:
    Sep 30, 2014
    Last Verified:
    Sep 1, 2014
    Keywords provided by Wafaa Mahmoud El-Sadr, Director, ICAP, Columbia University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 30, 2014